Immediate Impact
7 from Science/Nature 66 standout
Citing Papers
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
2024 Standout
Works of Tom Feys being referenced
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tom Feys | 243 | 194 | 16 | 71 | 7 | 346 | |
| Jennifer R. Czochor | 258 | 200 | 17 | 76 | 8 | 399 | |
| Marie-Hélène Renalier | 346 | 138 | 16 | 36 | 11 | 410 | |
| Benjamin T. Brett | 271 | 79 | 66 | 101 | 6 | 357 | |
| E S Rennel | 316 | 95 | 13 | 78 | 7 | 402 | |
| Helga Seyschab | 305 | 130 | 26 | 102 | 12 | 387 | |
| Gennaro De Vita | 320 | 211 | 14 | 48 | 5 | 389 | |
| F. Prins | 263 | 105 | 8 | 122 | 7 | 409 | |
| Bastiaan van der Roest | 182 | 136 | 44 | 93 | 7 | 325 | |
| Robert T. Morgan | 211 | 72 | 63 | 100 | 7 | 351 | |
| Kieren D. Marini | 220 | 76 | 14 | 115 | 9 | 316 |
All Works
Loading papers...